Ferroptosis induction via targeting metabolic alterations in head and neck cancer

被引:8
|
作者
Lee, Jaewang [1 ,2 ]
Roh, Jong-Lyel [1 ,2 ]
机构
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, Gyeonggi Do, South Korea
[2] CHA Univ, Gen Grad Sch, Dept Biomed Sci, Seongnam, South Korea
基金
新加坡国家研究基金会;
关键词
Metabolism; Mitochondria; Ferroptosis; Lipid peroxidation; Head and neck cancer; SQUAMOUS-CELL CARCINOMA; CISPLATIN-RESISTANT HEAD; NASOPHARYNGEAL CARCINOMA; LIPID DROPLETS; TUMOR-GROWTH; INHIBITION; IRON; DEATH; CELECOXIB; METASTASIS;
D O I
10.1016/j.critrevonc.2022.103887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is a newly regulated cell death induced by the accumulation of iron-mediated lipid peroxidation. The alteration of cancer metabolism may contribute to proliferation, metastasis, and treatment resistance in human cancers, implicating the sensitivity to ferroptosis induction. Altered metabolism in cancer cells regulates oxidative stresses and changes metabolism intermediates, contributing to their deregulated growth and prolif-eration. Cancer metabolic changes toward the elevation of cellular free iron and polyunsaturated fatty acids sensitize cancer cells to lipid peroxidation toxicity tightly linked to ferroptosis. The altered metabolism in cancers can be served as a promising target to reverse cancer therapeutic resistance by ferroptosis induction to selectively kill cancer cells while sparing normal cells. The role of mitochondria and lipid metabolism in inducing ferroptosis in head and neck cancer (HNC) has been elucidated in previous studies. Ferroptosis is receiving attention in cancer research as treating cancers altering cellular metabolism and refractory from conventional therapies. More in-depth studies are needed to develop highly therapeutic drugs and practical methods to induce ferroptosis in diverse cancer cells and tumor microenvironments effectively. Therefore, this review intends to understand the altered metabolism and find new therapeutic possibilities using ferroptosis in HNC.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Induction chemotherapy in head and neck cancer
    Hitt, R.
    ANNALS OF ONCOLOGY, 2006, 17 : X42 - X44
  • [22] Induction chemotherapy in head and neck cancer
    Adelstein, DJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (04) : 689 - +
  • [23] Induction Chemotherapy in Head and Neck Cancer
    Haddad, Robert I.
    Posner, Marshall R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : E52 - E53
  • [24] Induction chemotherapy for head and neck cancer
    Enokida, Tomohiro
    ANNALS OF ONCOLOGY, 2022, 33 : S441 - S441
  • [25] Targeting metabolic pathways for head and neck cancers therapeutics
    Masashi Yamamoto
    Hidenori Inohara
    Takashi Nakagawa
    Cancer and Metastasis Reviews, 2017, 36 : 503 - 514
  • [26] Targeting metabolic pathways for head and neck cancers therapeutics
    Yamamoto, Masashi
    Inohara, Hidenori
    Nakagawa, Takashi
    CANCER AND METASTASIS REVIEWS, 2017, 36 (03) : 503 - 514
  • [27] Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
    Jehl, Aude
    Conrad, Ombline
    Burgy, Mickael
    Foppolo, Sophie
    Vauchelles, Romain
    Ronzani, Carole
    Etienne-Selloum, Nelly
    Chenard, Marie-Pierre
    Danic, Aurelien
    Dourlhes, Thomas
    Thibault, Claire
    Schultz, Philippe
    Dontenwill, Monique
    Martin, Sophie
    CELLS, 2023, 12 (05)
  • [28] GENETIC ALTERATIONS IN HEAD AND NECK-CANCER
    SOMERS, KD
    SCHECHTER, GL
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1992, 25 (05) : 1065 - 1071
  • [29] Pterostilbene suppresses head and neck cancer cell proliferation via induction of apoptosis
    Ozdas, Talih
    Ozdas, Sibel
    Canatar, Ipek
    Kaypak, Erdem
    TURKISH JOURNAL OF BIOLOGY, 2024, 48 (05)
  • [30] Effect of ferroptosis on proliferation and tumor immunity in head and neck cancer
    Wakisaka, Risa
    Kumai, Takumi
    Kono, Michihisa
    Ohara, Kenzo
    Nagato, Toshihiro
    Ohkuri, Takayuki
    Kosaka, Akemi
    Kobayashi, Hiroya
    Takahara, Miki
    CANCER SCIENCE, 2025, 116 : 987 - 987